암행어사 vs ANRISK®
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
암행어사
Read full descriptionHide full description
암행어사는 암 예방 건강 관리 서비스로 국내 암 역학, 암 관리 및 정책 분야 최고의 전문가들이 기술한 국내 유일의 “암 역학 교과서”를 토대로 개발되었습니다. ▣ 건강 유형 서비스 - 16개의 건강 유형을 통해 현재 나의 건강 상태를 확인할 수 있어요. - 내 건강 유형에 맞는 캐릭터와 함께 건강관리를 시작해 보세요. ▣ 암 예방 정보 서비스 - 분석된 건강 상태를 통해 암 예방을 위한 정보를 확인할 수 있어요. ▣ 건강 검진 결과 모아보기 - 최근 10년간 국민건강보험공단에 기록된 건강검진 결과를 확인할 수 있어요. ▣병원 및 약국 기록 모아보기 - 최근 1년간 국민건강보험공단에 기록된 병원 및 약국 기록을 확인할 수 있어요. ▣ 건강 상태 심층 분석 - 암 예방 심층 분석 보고서를 통해 나의 건강 상태를 정밀하게 확인할 수 있어요. ※ 본 앱의 서비스는 의사로부터 얻는 정보, 진단, 치료를 대신할 수 없습니다. 직접 병원을 방문하여 정확한 진료와 자세한 상담을 받아보시기 바랍니다.
ANRISK®
Read full descriptionHide full description
"Brain aneurysm, the ticking time bomb in your head: Assess your risk solely based on screening results." Assess Your Brain Aneurysm Risk with ANRISK®—an AI Model Developed by Neurosurgeons. ■ Brain Aneurysms: Early Detection Is Key According to the Brain Aneurysm Foundation, a ruptured brain aneurysm has a fatality rate of 50%, but identifying risk factors early can significantly improve the risk level and prevent irreversible consequences. ■ Quick Analysis Using Basic Health Information ANRISK® is a non-generative AI model developed by a team of neurosurgery experts using 8.8 million person-years worth of data. It analyzes brain aneurysm risk based on 21 key variables such as age, sex, blood pressure, diabetes history, and smoking status. Users can receive a personalized risk score by entering basic health data—no additional tests are required. ■ Personalized Reports for Proactive Health Management Users receive an analysis report with a risk score and are categorized into one of five risk levels. The report also includes personalized health goals and lifestyle guidance to support proactive wellness and long-term risk awareness. ※ This app does not provide medical diagnosis or treatment. All health-related decisions should be made in consultation with a qualified professional. ■ ANRISK® Awards & Recognition *2023 Healthcare Big Data Startup Competition Grand Prize (Minister of Health and Welfare Award) - Rep. of Korea *CHALLENGE! K-Startup 2023 Innovation Startup League (General League) Grand Prize - Rep. of Korea *The 11th Pan Government Data Startup Competition Grand Prize (Presidential Award) - Rep. of Korea *LINA 50+ Awards (Creative Innovation) 1st place - Rep. of Korea ■ Important Disclaimer This app is designed to provide general health-related insights and should not be used for medical purposes. The information and risk scores provided are intended for personal awareness and wellness support only. They are not a substitute for professional medical advice, diagnosis, or treatment, and this app is not classified as a medical device. [Contact] hello@taloscorp.io
Screenshots
Verdict
The clearest difference is in-app purchases: 암행어사 at none against ANRISK®'s 3. 암행어사 also leads on iOS requirement (12.0 vs 15.1). ANRISK®'s advantage is device support. On price there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. ANRISK® sells 3 one-off in-app purchases. 암행어사 asks for nothing beyond the download.
| Parameter | 암행어사 | ANRISK® |
|---|---|---|
| Price | Free | Free |
| Update frequency | — | Every 2 months |
| Ads | — | No |
| In-app purchases | No — better | Yes |
| Devices | — | iPhone, iPad, iPod — better |
| Requires iOS | 12.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 109 MB | 80 MB |
| Age rating | 12+ | 17+ |
| Developer | aaihc | TALOS Corp. |
In-app purchases
암행어사
No in-app purchases
ANRISK®
- 1 ANRISK® Analysis Credit$19.99
- 5 ANRISK® Analysis Credits$99.99
- 10 ANRISK® Analysis Credits$199.99









